Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among TreatmentâExperienced Patients Infected with MultidrugâResistant HIV: Results of the ANRS 139 TRIO Trial